SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-16-000117
Filing Date
2016-06-07
Accepted
2016-06-07 17:15:06
Documents
90
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq12016.htm 10-Q 2000141
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 14535
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 14170
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 8725
5 EXHIBIT 32.2 exhibit322.htm EX-32.2 8338
  Complete submission text file 0000885590-16-000117.txt   12844899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrx-20160331.xml EX-101.INS 3435421
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20160331.xsd EX-101.SCH 67591
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20160331_cal.xml EX-101.CAL 108200
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20160331_lab.xml EX-101.LAB 929768
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20160331_pre.xml EX-101.PRE 609208
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20160331_def.xml EX-101.DEF 449557
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 161702047
SIC: 2834 Pharmaceutical Preparations